Ahmad Fatemi

Ahmad Fatemi

Auto-generated profile, based on publicly available information

Ahmad Fatemi

Cellular and Molecular Research Center, Gerash University of Medical Sciences, Gerash, Iran

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Life Sciences
Verified
Journal Article
Closed access
ZAZahra Ameri
Zahra Ameri
SGSaeedeh Ghiasi
Saeedeh Ghiasi
AFAlireza Farsinejad
Alireza Farsinejad
GHGholamhossein Hassanshahi
Gholamhossein Hassanshahi
MEMohsen Ehsan
Mohsen Ehsan
AFAhmad Fatemi
Ahmad Fatemi

1 October 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
NGNarges Ghasemimehr
Narges Ghasemimehr
AFAlireza Farsinejad
Alireza Farsinejad
RKRoohollah Mirzaee Khalilabadi
Roohollah Mirzaee Khalilabadi
ZYZinat Yazdani
Zinat Yazdani
AFAhmad Fatemi
Ahmad Fatemi

28 January 2020 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Open access
PDF file
MDMaryam Delfan
Maryam Delfan
MDMahmoud Delphan
Mahmoud Delphan
MKMohammd Reza Kordi
Mohammd Reza Kordi
ARAli Asghar Ravasi
Ali Asghar Ravasi
MSMajid Safa
Majid Safa
ENEnsieh Nasli-Esfahani
Ensieh Nasli-Esfahani
Purpose Diabetes and its complications such as diabetic cardiomyopathy still account for significant morbidity and mortality. High-quality evidence was shown the importance of exercise in controlling diabetes complications, but the molecular mechanism on diabetic cardiomyopathy is not yet fully understood. This study aimed to compare and investigate the effect of high intensity interval training (HIIT) and continuous endurance training (CET) on the signaling pathway of diabetic cardiomyopathy. Methods Hence, 21 Wistar rats with an average weight of 260 ± 10 g, after induction of diabetes (STZ 50 mg/kg BW) were randomly divided into three groups (control, CET and HIIT; n = 7). Training programs were conducted 5 days a week for 5 weeks. CET program was defined as running at 60% vVO2max for 30 min in each session and the HIIT program was defined as running at 85–90% vVO2max for 3 min followed by 1 min recovery (30–35% vVO2max), that was repeated four times in each session. The cardiac performance was analyzed via determination of end systolic and diastolic dimensions and the ejection fraction by echocardiography. To elucidate the responsible molecular mechanism of miR-1, IGF-1 and IGF-1R mRNA and apoptosis marker protein expression were investigated. Results Both training programs specifically HIIT, significantly reduced the blood glucose, enhanced heart performance, reduced miR-1 expression, induced IGF-1 and IGF-1R expression and reduced apoptotic protein expression. Conclusion We showed that HIIT is more effective than CET for reduction of diabetic cardiomyopathy as a complication of diabetes in animal models through suppressing miR-1 and its downstream apoptosis pathway.

25 July 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MLMahla Lashkari
Mahla Lashkari
AFAhmad Fatemi
Ahmad Fatemi
HVHajar Mardani Valandani
Hajar Mardani Valandani
RKRoohollah Mirzaee Khalilabadi
Roohollah Mirzaee Khalilabadi
One of the heterogeneous hematologic malignancies of the lymphocyte precursors is ALL. ALL has two incidence peaks that were determined in 2–5 years children and 60 years old adults. Cardiotoxicity of chemotherapeutic drugs is one of important side effects which may occur during or after chemotherapy period. The aim of this study was to evaluate the effect of ZME, Dox, and combinations on Nalm-6 cells. In this vein, the cell viability was assessed by Trypan blue and MTT assay. Evaluation of apoptosis was also analyzed by Annexin-V/PI staining. Moreover, the expression of Bax, Bcl-2, Bcl-xl, hTERT, c-Myc, P53, and P21 genes was detected by Real-Time PCR. Molecular docking as an in-silico method was performed for Bcl-2 and Bcl-xl proteins as well. Our achievements indicated that ZME had dose-dependent effect on Nalm-6 cells and ZME synergistically potentiated Dox effect. The expression of Bax, P53 and P21 genes increased although the expression of Bcl-2 genes decreased when cells treated with ZME/ Dox combination. Molecular docking showed the interactions of carvacrol and thymol in the active cavities of BCL2 and BCL-xl. Regarding to present study, ZME could be utilized as a combinatorial and potential drug for leukemic patients, which is under the treatment by Dox due to reducing the chemotherapy drug doses.

30 April 2019 in Experimental Hematology & Oncology
Verified
Journal Article
Open access
PDF file
AMAlireza Moradabadi
Alireza Moradabadi
AFAlireza Farsinejad
Alireza Farsinejad
BKBehzad Khansarinejad
Behzad Khansarinejad
AFAhamd Fatemi
Ahamd Fatemi
Myeloproliferative neoplasms (MPN) are heterogeneous diseases that classified by the presence of Philadelphia chromosome into Philadelphia chromosome negative (Ph-neg) and positive (Ph-pos) myeloproliferative neoplasms. In ph-neg group A somatic point mutation (c.1849G>T) in the JAK2 gene, part of the JAK2-STAT signal-transduction pathway, causes substitution of phenylalanine for valine (V617F) in the JAK2 protein and has been identified. This mutation was seen in PV by 65% to 97% and ET (30–57%) and primary myelofibrosis (35–95%). Highly sensitive methods have been used to determine the presence of the JAK2V617F mutation instead of direct sequencing. We aimed to assess JAK2 exon14 mutations by high-resolution melting (HRM) analysis, which allows variation screening in compare to other method for detecting mutation. The mutation analysis included 45 individuals who were subjected for diagnosis of ph-neg MPN. Genomic DNA was isolated and different methods are performed. PCR RFLP, ARMS PCR and HRM method has a detection sensitivity comparable with conventional methods (Qiagen) to identify the mutations and sequencing. For HRM analysis is cost-effective and beside that it is enzyme independence method also this method able to show amount of the mutant allele carried in samples and it’s helpful for treatments follow-up and determining MRD for them.

22 January 2024 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MKMaryam Katoueezadeh
Maryam Katoueezadeh
PMParisa Maleki
Parisa Maleki
STSeyedeh Atekeh Torabizadeh
Seyedeh Atekeh Torabizadeh
AFAlireza Farsinejad
Alireza Farsinejad
RKRoohollah Mirzaee Khalilabadi
Roohollah Mirzaee Khalilabadi
AFAhmad Fatemi
Ahmad Fatemi